BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17608639)

  • 21. Epidemiological investigation in outpatients with symptomatic gastroesophageal reflux from the Department of Medicine in Zhejiang Province, east China.
    Li YM; Du J; Zhang H; Yu CH
    J Gastroenterol Hepatol; 2008 Feb; 23(2):283-9. PubMed ID: 17645475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study.
    Monkemuller K; Neumann H; Nocon M; Vieth M; Labenz J; Willich SN; Stolte M; Hocker M; Jaspersen D; Lind T; Malfertheiner P
    Aliment Pharmacol Ther; 2008 Aug; 28(4):491-6. PubMed ID: 18557987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres.
    Danjo A; Yamaguchi K; Fujimoto K; Saitoh T; Inamori M; Ando T; Shimatani T; Adachi K; Kinjo F; Kuribayashi S; Mitsufuji S; Fujiwara Y; Koyama S; Akiyama J; Takagi A; Manabe N; Miwa H; Shimoyama Y; Kusano M
    J Gastroenterol Hepatol; 2009 Apr; 24(4):633-8. PubMed ID: 19220681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. There is no difference in the disease severity of gastro-oesophageal reflux disease between patients infected and not infected with Helicobacter pylori.
    Fallone CA; Barkun AN; Mayrand S; Wakil G; Friedman G; Szilagyi A; Wheeler C; Ross D
    Aliment Pharmacol Ther; 2004 Oct; 20(7):761-8. PubMed ID: 15379836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence and pattern of gastroesophageal reflux symptoms in perimenopausal and menopausal women.
    Infantino M
    J Am Acad Nurse Pract; 2008 May; 20(5):266-72. PubMed ID: 18460167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up.
    Kim N; Park RY; Cho SI; Lim SH; Lee KH; Lee W; Kang HM; Lee HS; Jung HC; Song IS
    J Clin Gastroenterol; 2008; 42(5):448-54. PubMed ID: 18344895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of HP eradication on the development of gastroesophageal reflux disease: results of the prospective study].
    Pasechnikov VD; Chotchaeva AR; Pasechnikov DV
    Eksp Klin Gastroenterol; 2011; (3):105-10. PubMed ID: 21695958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persisting chronic gastritis and elevated Helicobacter pylori antibodies after successful eradication therapy.
    Veijola L; Oksanen A; Linnala A; Sipponen P; Rautelin H
    Helicobacter; 2007 Dec; 12(6):605-8. PubMed ID: 18001400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laryngopharyngeal symptoms and gastroesophageal reflux disease.
    Rouev P; Chakarski I; Doskov D; Dimov G; Staykova E
    J Voice; 2005 Sep; 19(3):476-80. PubMed ID: 15936924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The presence of dental disease can be a risk factor for recurrent Helicobacter pylori infection after eradication therapy: a 3-year follow-up.
    Sheu BS; Cheng HC; Yang YJ; Yang HB; Wu JJ
    Endoscopy; 2007 Nov; 39(11):942-7. PubMed ID: 17886199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Migrant communities constitute a possible target population for primary prevention of Helicobacter pylori-related complications in low incidence countries.
    De Vries AC; Van Driel HF; Richardus JH; Ouwendijk M; Van Vuuren AJ; De Man RA; Kuipers EJ
    Scand J Gastroenterol; 2008; 43(4):403-9. PubMed ID: 18365904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study.
    Tran T; Spechler SJ; Richardson P; El-Serag HB
    Am J Gastroenterol; 2005 May; 100(5):1002-8. PubMed ID: 15842570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An inverse relation between CagA+ strains of Helicobacter pylori infection and risk of erosive GERD.
    Somi MH; Fattahi E; Fouladi RF; Karimi M; Bonyadi R; Baballou Z
    Saudi Med J; 2008 Mar; 29(3):393-6. PubMed ID: 18327366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer.
    Ogura K; Hirata Y; Yanai A; Shibata W; Ohmae T; Mitsuno Y; Maeda S; Watabe H; Yamaji Y; Okamoto M; Yoshida H; Kawabe T; Omata M
    J Clin Gastroenterol; 2008 Mar; 42(3):279-83. PubMed ID: 18223496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and precipitating factors of gastroesophageal reflux disease in a young population of Tabriz, Northwest of Iran.
    Somi MH; Farhang S; Mirinezhad K; Jazayeri E; Nasseri-Moghaddam S; Moayeri S; Yasrebinia S
    Saudi Med J; 2006 Dec; 27(12):1878-81. PubMed ID: 17143368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of presentation of common functional gastrointestinal disorders in children from birth to 5 years: a cohort study.
    Chitkara DK; Talley NJ; Weaver AL; Katusic SK; De Schepper H; Rucker MJ; Locke GR
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):186-91. PubMed ID: 16901769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastroesophageal reflux disease in a low-income region in Turkey.
    Bor S; Mandiracioglu A; Kitapcioglu G; Caymaz-Bor C; Gilbert RJ
    Am J Gastroenterol; 2005 Apr; 100(4):759-65. PubMed ID: 15784016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay.
    Sun LP; Gong YH; Wang L; Gong W; Yuan Y
    J Dig Dis; 2008 Feb; 9(1):20-6. PubMed ID: 18251790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.